PMID- 31108178 OWN - NLM STAT- MEDLINE DCOM- 20200330 LR - 20200330 IS - 1878-4216 (Electronic) IS - 0278-5846 (Linking) VI - 94 DP - 2019 Aug 30 TI - Histamine H(3) receptor activation reduces the impairment in prepulse inhibition (PPI) of the acoustic startle response and Akt phosphorylation induced by MK-801 (dizocilpine), antagonist at N-Methyl-d-Aspartate (NMDA) receptors. PG - 109653 LID - S0278-5846(18)30982-5 [pii] LID - 10.1016/j.pnpbp.2019.109653 [doi] AB - We have investigated the effect of the local activation of histamine H(3) receptors (H(3)Rs) in the rat prefrontal cortex (PFCx) on the impairment of pre-pulse inhibition (PPI) of the startle response induced by the systemic administration of MK-801, antagonist at glutamate N-Methyl-d-Aspartate (NMDA) receptors, and the possible functional interaction between H(3)Rs and MK-801 on PFCx dopaminergic transmission. Infusion of the H(3)R agonist RAMH (19.8 ng/1 mul) into the PFCx reduced or prevented the inhibition by MK-801 (0.15 mg/kg, ip) of PPI evoked by different auditory stimulus intensities (5, 10 and 15 dB), and the RAMH effect was blocked by the H(3)R antagonist/inverse agonist ciproxifan (30.6 ng/1 mul). MK-801 inhibited [(3)H]-dopamine uptake (-45.4 +/- 2.1%) and release (-32.8 +/- 2.6%) in PFCx synaptosomes or slices, respectively, and molecular modeling indicated that MK-801 binds to and blocks the rat and human dopamine transporters. However, H(3)R activation had no effect on the inhibitory action of MK-801 on dopamine uptake and release. In PFCx slices, MK-801 and the activation of H(3)Rs or dopamine D(1) receptors (D(1)Rs) stimulated ERK-1/2 and Akt phosphorylation. The co-activation of D(1)Rs and H(3)Rs prevented ERK-1/2 and Akt phosphorylation, and H(3)R activation or D(1)R blockade prevented the effect of MK-801. In ex vivo experiments, the intracortical infusion of the D(1)R agonist SKF-81297 (37 ng/1 mul) or the H(3)R agonist RAMH increased Akt phosphorylation, prevented by D(1)R/H(3)R co-activation. These results indicate that MK-801 enhances dopaminergic transmission in the PFCx, and that H(3)R activation counteracts the post-synaptic actions of dopamine. CI - Copyright (c) 2019 Elsevier Inc. All rights reserved. FAU - Aquino-Miranda, Guillermo AU - Aquino-Miranda G AD - Doctorado en Ciencias Biologicas y de la Salud, Universidad Autonoma Metropolitana Unidad Xochimilco, Ciudad de Mexico, Mexico; Departamento de Fisiologia, Biofisica y Neurociencias, Centro de Investigacion y de Estudios Avanzados (Cinvestav) del IPN, Av. IPN 2508, 07360 Ciudad de Mexico, Mexico. FAU - Rivera-Ramirez, Nayeli AU - Rivera-Ramirez N AD - Departamento de Fisiologia, Biofisica y Neurociencias, Centro de Investigacion y de Estudios Avanzados (Cinvestav) del IPN, Av. IPN 2508, 07360 Ciudad de Mexico, Mexico. FAU - Marquez-Gomez, Ricardo AU - Marquez-Gomez R AD - Departamento de Fisiologia, Biofisica y Neurociencias, Centro de Investigacion y de Estudios Avanzados (Cinvestav) del IPN, Av. IPN 2508, 07360 Ciudad de Mexico, Mexico. FAU - Escamilla-Sanchez, Juan AU - Escamilla-Sanchez J AD - Departamento de Fisiologia, Biofisica y Neurociencias, Centro de Investigacion y de Estudios Avanzados (Cinvestav) del IPN, Av. IPN 2508, 07360 Ciudad de Mexico, Mexico. FAU - Gonzalez-Pantoja, Raul AU - Gonzalez-Pantoja R AD - Departamento de Fisiologia, Biofisica y Neurociencias, Centro de Investigacion y de Estudios Avanzados (Cinvestav) del IPN, Av. IPN 2508, 07360 Ciudad de Mexico, Mexico. FAU - Ramos-Languren, Laura-Elisa AU - Ramos-Languren LE AD - Coordinacion de Psicobiologia y Neurociencias, Facultad de Psicologia, UNAM, Av. Universidad 3004, 04510 Ciudad de Mexico, Mexico. FAU - Perez-Neri, Ivan AU - Perez-Neri I AD - Departamento de Neuroquimica, Instituto Nacional de Neurologia y Neurocirugia SSa, Av. Insurgentes Sur 3877, 14269 Ciudad de Mexico, Mexico. FAU - Bueno-Nava, Antonio AU - Bueno-Nava A AD - Division de Neurociencias, Instituto Nacional de Rehabilitacion, SSa, Calzada Mexico-Xochimilco 289, 14389 Ciudad de Mexico, Mexico. FAU - Rios, Camilo AU - Rios C AD - Departamento de Neuroquimica, Instituto Nacional de Neurologia y Neurocirugia SSa, Av. Insurgentes Sur 3877, 14269 Ciudad de Mexico, Mexico; Laboratorio de Neurofarmacologia Molecular, Departamento de Sistemas Biologicos, Universidad Autonoma Metropolitana, Unidad Xochimilco, Calzada del Hueso 1100, 04960 Ciudad de Mexico, Mexico. FAU - Arias-Montano, Jose-Antonio AU - Arias-Montano JA AD - Departamento de Fisiologia, Biofisica y Neurociencias, Centro de Investigacion y de Estudios Avanzados (Cinvestav) del IPN, Av. IPN 2508, 07360 Ciudad de Mexico, Mexico. Electronic address: jaarias@fisio.cinvestav.mx. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20190517 PL - England TA - Prog Neuropsychopharmacol Biol Psychiatry JT - Progress in neuro-psychopharmacology & biological psychiatry JID - 8211617 RN - 0 (Benzazepines) RN - 0 (Dopamine Plasma Membrane Transport Proteins) RN - 0 (Excitatory Amino Acid Antagonists) RN - 0 (Histamine Agonists) RN - 0 (Imidazoles) RN - 0 (Receptors, Histamine H3) RN - 0 (Receptors, N-Methyl-D-Aspartate) RN - 10028-17-8 (Tritium) RN - 5EVQ7IRG99 (ciproxifan) RN - 6LR8C1B66Q (Dizocilpine Maleate) RN - 71636-61-8 (SK&F 81297) RN - EC 2.7.11.1 (Proto-Oncogene Proteins c-akt) RN - EC 2.7.11.24 (Mitogen-Activated Protein Kinase 1) RN - EC 2.7.11.24 (Mitogen-Activated Protein Kinase 3) RN - VTD58H1Z2X (Dopamine) SB - IM MH - Animals MH - Benzazepines/administration & dosage/pharmacology MH - Dizocilpine Maleate/administration & dosage/*pharmacology MH - Dopamine/metabolism MH - Dopamine Plasma Membrane Transport Proteins/metabolism MH - Excitatory Amino Acid Antagonists/pharmacology MH - Histamine Agonists/administration & dosage/pharmacology MH - Imidazoles/administration & dosage/pharmacology MH - Male MH - Microinjections MH - Mitogen-Activated Protein Kinase 1/metabolism MH - Mitogen-Activated Protein Kinase 3/metabolism MH - Molecular Docking Simulation MH - Phosphorylation/drug effects MH - Prefrontal Cortex/drug effects/metabolism MH - Prepulse Inhibition/*drug effects MH - Proto-Oncogene Proteins c-akt/*metabolism MH - Rats MH - Receptors, Histamine H3/*metabolism MH - Receptors, N-Methyl-D-Aspartate/*antagonists & inhibitors/metabolism MH - Reflex, Startle/*drug effects MH - Tritium/metabolism OTO - NOTNLM OT - Dopamine OT - Histamine OT - Histamine H(3) receptor OT - MK-801 OT - Prefrontal cortex OT - Schizophrenia EDAT- 2019/05/21 06:00 MHDA- 2020/03/31 06:00 CRDT- 2019/05/21 06:00 PHST- 2018/12/19 00:00 [received] PHST- 2019/05/14 00:00 [revised] PHST- 2019/05/15 00:00 [accepted] PHST- 2019/05/21 06:00 [pubmed] PHST- 2020/03/31 06:00 [medline] PHST- 2019/05/21 06:00 [entrez] AID - S0278-5846(18)30982-5 [pii] AID - 10.1016/j.pnpbp.2019.109653 [doi] PST - ppublish SO - Prog Neuropsychopharmacol Biol Psychiatry. 2019 Aug 30;94:109653. doi: 10.1016/j.pnpbp.2019.109653. Epub 2019 May 17.